FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382046585> ?p ?o ?g. }

• W4382046585 endingPage "164" @default.
• W4382046585 startingPage "155" @default.
• W4382046585 abstract "Glomerular diseases (GDs) represent the third leading cause of end-stage kidney disease (ESKD) in the US Diabetes was excluded from the CureGN Study, an NIH/NIDDK-sponsored observational cohort study of four leading primary GDs: IgA nephropathy (IgAN), membranous nephropathy (MN), focal segmental glomerulosclerosis (FSGS), and minimal change disease (MCD). CureGN-Diabetes, an ancillary study to CureGN, seeks to understand how diabetes influences the diagnosis, treatment, and outcomes of GD. It is a multicenter, prospective cohort study, targeting an enrollment of 300 adults with prevalent type 1 or type 2 diabetes and MCD, FSGS, MN, or IgAN, with first kidney biopsy obtained within 5 years of enrollment in 80% (20% allowed if biopsy after 2010). CureGN and Transformative Research in DiabEtic NephropaThy (TRIDENT) provide comparator cohorts. Retrospective and prospective clinical data and patient-reported outcomes are obtained. Blood and urine specimens are collected at study visits annually. Kidney biopsy reports and digital images are obtained, and standardized pathologic evaluations performed. Light microscopy images are uploaded to the NIH pathology repository. Outcomes include relapse and remission rates, changes in proteinuria and estimated glomerular filtration rate, infections, cardiovascular events, malignancy, ESKD, and death. Multiple analytical approaches will be used leveraging the baseline and longitudinal data to compare disease presentation and progression across subgroups of interest. With 300 patients and an average of 3 years of follow-up, the study has 80% power to detect a HR of 1.4–1.8 for time to complete remission of proteinuria, a rate ratio for hospitalizations of 1.18–1.56 and difference in eGFR slope of 6.0–8.6 mL/min/year between two groups of 300 participants each. CureGN-Diabetes will enhance our understanding of diabetes as a modifying factor of the pathology and outcomes of GDs and support studies to identify disease mechanisms and improve patient outcomes in this understudied patient population." @default.
• W4382046585 created "2023-06-27" @default.
• W4382046585 creator A5000037148 @default.
• W4382046585 creator A5000517864 @default.
• W4382046585 creator A5003868070 @default.
• W4382046585 creator A5009128263 @default.
• W4382046585 creator A5020058756 @default.
• W4382046585 creator A5020252530 @default.
• W4382046585 creator A5020881383 @default.
• W4382046585 creator A5023211777 @default.
• W4382046585 creator A5030709399 @default.
• W4382046585 creator A5042418162 @default.
• W4382046585 creator A5044968606 @default.
• W4382046585 creator A5047016559 @default.
• W4382046585 creator A5052803211 @default.
• W4382046585 creator A5054993212 @default.
• W4382046585 creator A5057297665 @default.
• W4382046585 creator A5058422244 @default.
• W4382046585 creator A5066638505 @default.
• W4382046585 creator A5080390560 @default.
• W4382046585 creator A5085929764 @default.
• W4382046585 date "2023-06-26" @default.
• W4382046585 modified "2023-10-18" @default.
• W4382046585 title "CureGN-Diabetes Study: Rationale, Design, and Methods of a Prospective Observational Study of Glomerular Disease Patients with Diabetes" @default.
• W4382046585 cites W1987380823 @default.
• W4382046585 cites W1996571958 @default.
• W4382046585 cites W2012093680 @default.
• W4382046585 cites W2038390766 @default.
• W4382046585 cites W2041514348 @default.
• W4382046585 cites W2047186012 @default.
• W4382046585 cites W2072739923 @default.
• W4382046585 cites W2080815265 @default.
• W4382046585 cites W2085975668 @default.
• W4382046585 cites W2136490577 @default.
• W4382046585 cites W2148983669 @default.
• W4382046585 cites W2151438241 @default.
• W4382046585 cites W2155492217 @default.
• W4382046585 cites W2164289320 @default.
• W4382046585 cites W2170271709 @default.
• W4382046585 cites W2170767337 @default.
• W4382046585 cites W2186629139 @default.
• W4382046585 cites W2267406432 @default.
• W4382046585 cites W2741457765 @default.
• W4382046585 cites W2766335386 @default.
• W4382046585 cites W2788324419 @default.
• W4382046585 cites W2898491544 @default.
• W4382046585 cites W2899995215 @default.
• W4382046585 cites W2953848769 @default.
• W4382046585 cites W2983691809 @default.
• W4382046585 cites W2991197074 @default.
• W4382046585 cites W2997404865 @default.
• W4382046585 cites W3004578412 @default.
• W4382046585 cites W3035523408 @default.
• W4382046585 cites W3044576032 @default.
• W4382046585 cites W3082278640 @default.
• W4382046585 cites W3128205593 @default.
• W4382046585 cites W3132608056 @default.
• W4382046585 cites W3157101051 @default.
• W4382046585 cites W3159637109 @default.
• W4382046585 cites W3174153620 @default.
• W4382046585 cites W4281682376 @default.
• W4382046585 doi "https://doi.org/10.1159/000531679" @default.
• W4382046585 hasPublicationYear "2023" @default.
• W4382046585 type Work @default.
• W4382046585 citedByCount "1" @default.
• W4382046585 crossrefType "journal-article" @default.
• W4382046585 hasAuthorship W4382046585A5000037148 @default.
• W4382046585 hasAuthorship W4382046585A5000517864 @default.
• W4382046585 hasAuthorship W4382046585A5003868070 @default.
• W4382046585 hasAuthorship W4382046585A5009128263 @default.
• W4382046585 hasAuthorship W4382046585A5020058756 @default.
• W4382046585 hasAuthorship W4382046585A5020252530 @default.
• W4382046585 hasAuthorship W4382046585A5020881383 @default.
• W4382046585 hasAuthorship W4382046585A5023211777 @default.
• W4382046585 hasAuthorship W4382046585A5030709399 @default.
• W4382046585 hasAuthorship W4382046585A5042418162 @default.
• W4382046585 hasAuthorship W4382046585A5044968606 @default.
• W4382046585 hasAuthorship W4382046585A5047016559 @default.
• W4382046585 hasAuthorship W4382046585A5052803211 @default.
• W4382046585 hasAuthorship W4382046585A5054993212 @default.
• W4382046585 hasAuthorship W4382046585A5057297665 @default.
• W4382046585 hasAuthorship W4382046585A5058422244 @default.
• W4382046585 hasAuthorship W4382046585A5066638505 @default.
• W4382046585 hasAuthorship W4382046585A5080390560 @default.
• W4382046585 hasAuthorship W4382046585A5085929764 @default.
• W4382046585 hasBestOaLocation W43820465851 @default.
• W4382046585 hasConcept C126322002 @default.
• W4382046585 hasConcept C126894567 @default.
• W4382046585 hasConcept C134018914 @default.
• W4382046585 hasConcept C159641895 @default.
• W4382046585 hasConcept C188816634 @default.
• W4382046585 hasConcept C2777180221 @default.
• W4382046585 hasConcept C2777747828 @default.
• W4382046585 hasConcept C2778415529 @default.
• W4382046585 hasConcept C2778653478 @default.
• W4382046585 hasConcept C2779561371 @default.
• W4382046585 hasConcept C2779922275 @default.
• W4382046585 hasConcept C2780091579 @default.

• next